Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Relevant Immune Checkpoints Expressed on Metastatic Prostate Cancer Circulating Tumor Cells

NCT02456571 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02456571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02456571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Relevant Immune Checkpoints Expressed on Metastatic Prostate Cancer Circulating Tumor Cells
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
November 30, 2016
Completion date
June 13, 2019
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer